Press release
Global Ocular Drug Delivery Market Growth Prospects, Future Industry Landscape 2033 | Pfizer Inc., Roche Holding AG, AbbVie Inc., Novartis AG, Allergan Inc., Regeneron Pharmaceuticals Inc
Ocular Drug Delivery Global Market Report 2024
The Business Research Company offers in-depth market insights through Ocular Drug Delivery Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The ocular drug delivery market size has grown strongly in recent years. It will grow from $17.39 billion in 2023 to $18.64 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to rise in ocular diseases, aging population trends, advancements in pharmaceutical formulations, clinical advancements in ophthalmology, prevalence of diabetes-related eye conditions..
The ocular drug delivery market size is expected to see strong growth in the next few years. It will grow to $24.98 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to rising incidence of age-related eye diseases, focus on personalized medicine in ophthalmology, increased investment in ophthalmic research, demand for prolonged drug release, global initiatives for eye health.. Major trends in the forecast period include integration of smart drug delivery devices, personalized medicine in ocular drug formulations, development of topical ophthalmic therapies, collaborations for cross-industry innovations..
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=11901&type=smp
Market Segmentation:
The ocular drug delivery market covered in this report is segmented -
1) By Technology: Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems, Nano-Particle Drug Delivery System, Other Technologies
2) By Formulation: Liposomes And Nanoparticles, Solution, Emulsion, Suspension, Ointment
3) By Disease: Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Macular Degeneration, Cataract, Diabetic Macular Edema, Other Diseases
4) By End User: Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers
Major Driver - Rising Prevalence Of Eye Disorders Boosts Ocular Drug Delivery Market
An increase in the prevalence of eye disorders is expected to propel the growth of the ocular drug delivery market going forward. Eye disorders refer to a wide range of conditions that affect the eyes, vision, or the structures surrounding the eyes. Ocular drug delivery allocates medications directly to the target site, providing greater drug concentrations at the targeted area, optimizing therapeutic efficacy while avoiding systemic adverse effects, and improving eye disorders. For instance, in March 2023, according to the World Health Organization, a Switzerland-based United Nations agency, globally, 2.2 billion people will have a near- or far-sighted impairment. According to estimates, cataracts (94 million) and uncorrected refractive problems (88.4 million) are the main causes of visual loss or impaired vision. In addition, glaucoma (7.7 million cases), corneal opacities (4.2 million cases), diabetic retinopathy (3.9 million cases), and trachoma (2 million cases) are the other common causes of vision loss. Therefore, the increase in the prevalence of eye disorders is driving the growth of the ocular drug delivery market.
Competitive Landscape:
Major companies operating in the ocular drug delivery market report are Pfizer Inc., Roche Holding AG, AbbVie Inc., Novartis AG, Allergan Inc., Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Genentech Inc., Santen Pharmaceutical Co. Ltd., Akorn Inc., Valeant Pharmaceuticals International Inc., Aerie Pharmaceuticals Inc., Alimera Sciences Inc., Ocular Therapeutix Inc., Ophthotech Corporation, Acucela Inc., Graybug Vision Inc., Amakem NV, Kala Pharmaceuticals Inc., Icon Bioscience Inc., Clearside Biomedical Inc., Aerpio Therapeutics Inc., Senju Pharmaceutical Co. Ltd., Shire plc, Spark Therapeutics Inc., Sucampo Pharmaceuticals Inc., Carl Zeiss Meditec AG, EyeGate Pharmaceuticals Inc.
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/ocular-drug-delivery-global-market-report
Top Trend - Pioneering Product Innovations In The Ocular Drug Delivery Market
Product innovation is a key trend gaining popularity in the ocular drug delivery market. Companies operating in the ocular drug delivery market are focused on developing new product innovations to sustain their position in the market. For instance, in March 2023, Alcon AG, a Swiss pharmaceutical and medical device firm focusing on eye care products, launched TOTAL30 for astigmatism and SYSTANE HYDRATION for dry eye and ocular health. TOTAL30 is the debut and only Toric lens to combine water Gradient and Celligent Technology, allowing the lens that mimics the structure of the ocular surface and provides superior performance in areas like comfort, stability, and visual acuity. SYSTANE HYDRATION PF is an ocular health eye drop that uses HydroBoost technology to restore moisture, prevent irritation, and give relief from dry eye symptoms.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Ocular Drug Delivery Market Characteristics
3. Ocular Drug Delivery Market Trends And Strategies
4. Ocular Drug Delivery Market - Macro Economic Scenario
5. Ocular Drug Delivery Market Size And Growth
…..
27. Ocular Drug Delivery Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Ocular Drug Delivery Market Growth Prospects, Future Industry Landscape 2033 | Pfizer Inc., Roche Holding AG, AbbVie Inc., Novartis AG, Allergan Inc., Regeneron Pharmaceuticals Inc here
News-ID: 3429734 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Ocular
How the Ocular Pain Market Is Growing in 2025 | What's New Treatments Are Coming …
According to the IMARC Group, the ocular pain market is expected to exhibit a CAGR of 7.66% during 2025-2035. This can be attributed to the growing use of services in teleophthalmology, which facilitates remote consultations and enhances patient adherence.
Ocular pain is the discomfort or distress experienced within or around the eye. The ocular pain market is experiencing significant growth driven by multiple factors. Primarily, the increasing prevalence of conditions such…
Key Influencer in the Ocular Implants Market 2025: Growing Geriatric Population …
What market dynamics are playing a key role in accelerating the growth of the ocular implants market?
The growth of the ocular implants market is foreseen to be driven by the global increase in the geriatric population. The term 'geriatric population' is specifically used to refer to individuals aged 65 years or above. Ocular implants offer a solution to age-specific eye ailments prevalent among the elderly, such as cataracts, glaucoma, and…
Neuropathic Ocular Pain Market Is Booming Worldwide 2025-2032 | OKYO Pharma, Lim …
Latest Report, titled "Neuropathic Ocular Pain Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Neuropathic Ocular Pain market has been…
Neuropathic Ocular Pain Market Detailed In New Research Report 2024 |OKYO Pharma …
A recent report from Coherent Market Insight titled "Neuropathic Ocular Pain Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2031" presents a thorough examination of the industry landscape, offering insights into market analysis and trends. Alongside competitor and regional analysis, the report delves into contemporary advancements within the market.
Global Neuropathic Ocular Pain market is estimated to be valued at US$ 197.1 million in 2023 and is expected to…
Ocular Neuropathic Pain Market to witness Robust Expansion by 2031 - OKYO Pharma …
Ocular neuropathic pain (ONP) is chronic eye pain caused by nerve damage or dysfunction. It can result from various conditions, such as corneal nerve injury, ocular surgeries, infections, or systemic diseases like diabetes. Patients experience persistent, burning, or stabbing eye pain, often without visible signs of inflammation. Diagnosis involves detailed patient history, clinical examination, and sometimes specialized tests. Treatment focuses on managing pain and may include topical or systemic medications,…
Ocular Implant Market - Redefining Ophthalmic Solutions: Choose Ocular Implants …
Newark, New Castle, USA: The "Ocular Implant Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Ocular Implant Market: https://www.growthplusreports.com/report/ocular-implant-market/7864
This latest report researches the industry structure, sales, revenue,…
